Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9HC10: Variant p.Arg773Ser

Otoferlin
Gene: OTOF
Feedback?
Variant information Variant position: help 773 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Serine (S) at position 773 (R773S, p.Arg773Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page



Sequence information Variant position: help 773 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1997 The length of the canonical sequence.
Location on the sequence: help KSYPERRLRGVLEELSCGCC R FLSLADKDQGHSSRTRLDRE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         KSYPERRLRGVLEELSCGCCRFLSLADKDQGHSSRTRLDRE

Mouse                         KSYPERRLRGVLEELSCGCHRFLSLSDKDQGRSSRTRLDRE

Rat                           KSYPERRLRGVLEELSCGCHRFLSLSDKDQGHSSRTRLDRE

Zebrafish                     KAYPERRLRGVLEELSTSCSRFVTLANKDQNLSGRTKLDRE

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1997 Otoferlin
Topological domain 1 – 1963 Cytoplasmic



Literature citations
Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing loss.
Migliosi V.; Modamio-Hoeybjoer S.; Moreno-Pelayo M.A.; Rodriguez-Ballesteros M.; Villamar M.; Telleria D.; Menendez I.; Moreno F.; Del Castillo I.;
J. Med. Genet. 39:502-506(2002)
Cited for: VARIANTS CYS-82 AND SER-773; OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele.
Varga R.; Avenarius M.R.; Kelley P.M.; Keats B.J.; Berlin C.I.; Hood L.J.; Morlet T.G.; Brashears S.M.; Starr A.; Cohn E.S.; Smith R.J.H.; Kimberling W.J.;
J. Med. Genet. 43:576-581(2006)
Cited for: VARIANTS DFNB9 GLN-490; HIS-794 AND ALA-1825; VARIANTS AUNB1 THR-515; PRO-1011; GLN-1939 AND ARG-1987; VARIANTS VAL-53; CYS-82; MET-575; SER-773; TRP-822; PRO-1083; GLN-1157; GLU-1322; MET-1625; SER-1646 AND ASP-1888;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.